Cancer: Page 5

AccuStem Sciences and EmeritusDX team up on breast cancer assay, product portfolio

Initially, the partnership will focus on furthering the validation of StemPrintER, AccuStem’s recurrence predictor assay for patients with breast cancer.

July 19, 2023

Quest launches biomarker test to improve grading of prostate cancer biopsies

Building on the Australian research and working with Envision Sciences, the Australian diagnostics company that owns the biomarker intellectual property, Quest’s subspecialty pathology business, AmeriPath, has developed a tissue-based test.

July 17, 2023

Epigenetic study links DNA methylation to diseases including breast cancer and diabetes

Through the analysis, the researchers identified 69 associations between CpGs and the prevalence of breast cancer, chronic kidney disease, ischemic heart disease, and type 2 diabetes. The majority of the associations had not previously been described.

July 12, 2023

Pfizer invests $25M to support development of CellCentric’s blood cancer candidate

Evidence of the roles p300 and CBP play in multiple cancers led CellCentric to generate chemical hits against the proteins, ultimately leading to the development of inobrodib.

July 13, 2023

Cancer detection firm Elypta awarded quality certification

The scope of the certification includes the design and development of in vitro diagnostic (IVD) test kits and software for Elypta’s liquid biopsy-based platform for the detection and measurement of glycosaminoglycans (GAGomes) across different cancers.

July 7, 2023

Castle Biosciences reports study validation for melanoma gene expression test

The study findings support results from a recently published study which showed that patients who received routine imaging guided by high-risk 31-GEP test scores had earlier diagnoses of recurrence, which in turn led to better outcomes for patients.

July 6, 2023

LAMH receives Chinese approval for blood test designed to accelerate liver cancer diagnosis

The test was based on the multianalyte blood test HelioLiver, developed by Helio Genomics, and adapted for the genetics of the Asia-Pacific population, resulting in a product that could help address a major healthcare challenge in China.

July 5, 2023

DermTech moves to lay off 40 people, focuses on melanoma test to reduce spending

DermTech is reducing its workforce by 15% as part of a restructuring that will see the company suspend pipeline programs and focus on growing sales of its DMT melanoma test.

June 30, 2023

Genomics AI firm Genomenon acquires Boston Genetics

An expanded genomic interpretation team enabled by the acquisition supports its offerings for clinical diagnostic and pharmaceutical drug development programs, Genomenon said.

June 27, 2023

President Biden launches $50M initiative to improve cancer outcomes in low-income areas

The award creates five Centers for Cancer Control Research in Persistent Poverty Areas to advance key priorities of the Administration’s Cancer Moonshot.

June 26, 2023

Harvard Medical School, RareCyte developing multiplex imaging for clinical pathology

Multiplex imaging technology enables the integration of microscopic analysis with the visualization of molecular markers in individual cells.

June 26, 2023

Gene mutations linked to drug-resistant liver cancer

Certain gene mutations could help physicians predict which hepatocellular carcinoma patients are most likely to develop drug resistance to lenvatinib.

June 26, 2023

Previous Page

Page 5 of 93

Next Page